$heff's $tation of $tocks & $olid DD

[$heff]

New Economy Portfolio Update..bought a stock that should garner some interest throughout the summer as they await key top-line data scheduled to be released at the end of August. Trading in a tight range the pas t few weeks at $1.65-$1.75 range. The market cap is 87m & the trading range is $.92-$2.75.

Should have a nice catalyst move into August. Looking for a move possibly in the $2.25-2.50 range or higher. Analyst coverage is Scott Henry (ROTH) & Irene Kopfler (Cantor Fitzgerald). Strong Institutional buying as well

Alert..bought $APRI at $1.73 (8% Solid) in the New Economy Portfolio. It’s a Mid range $1 stock that could move higher into their Phase 2A Proof Of Concept study (RayVa) for the treatment of Raynaud’s Phenomenom in August.

$APRI.. Last Patient Enrolled in RayVa Ph.2a Trial. Top-line Data Expected Q3. http://t.co/AC3hBD9EXr

$APRI-http://www.streetinsider.com/Corporate+News/Apricus+Biosciences+(APRI)+Concludes+Enrollment+in+RayVa+Phase+2a/10650089.html

$APRI..Institutional Holding have substantially increased. Sarissa Holdings (Alex Denner) is the largest shareholder.



Disclaimer..http://bit.ly/OlN9DB